Changes in adjuvant therapy utilization in stage I seminoma: Are they enough to prevent overtreatment?

Urology

Volumn 84, Issue 6, 2014, Pages 1319-1324

  Kohut, Robert M ^a   Minnillo, Brian J ^a   Kypriotakis, Georgios ^b   Abouassaly, Robert ^a   Zhu, Hui ^c,d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; COMPARATIVE STUDY; FOLLOW UP; HEALTH CARE MANAGEMENT; HEALTH CARE UTILIZATION; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SEMINOMA; SOLID TUMOR; TESTIS CARCINOMA; UNITED STATES; ADJUVANT CHEMOTHERAPY; ADULT; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; ORCHIECTOMY; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; UNNECESSARY PROCEDURE; UTILIZATION;

ADULT; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORCHIECTOMY; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEMINOMA; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TESTICULAR NEOPLASMS; TREATMENT OUTCOME; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 84922275847     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2014.06.078     Document Type: Article

References (25)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. J.S. Townsend, L.C. Richardson, and R.R. German Incidence of testicular cancer in the United States, 1999-2004 Am J Mens Health 4 2010 353 360
3. K.A. McGlynn, S.S. Devesa, and A.J. Sigurdson et al. Trends in the incidence of testicular germ cell tumors in the United States Cancer 97 2003 63 70
4. T. Tandstad, R. Smaaland, and A. Solberg et al. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish Norwegian Testicular Cancer Study Group J Clin Oncol 29 2011 719 725
5. C. Kollmannsberger, S. Tyldesley, and C. Moore et al. Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies Ann Oncol 22 2011 808 814
6. C.R. Nichols, B. Roth, and P. Albers et al. Active surveillance is the preferred approach to clinical stage I testicular cancer J Clin Oncol 31 2013 3490 3493
7. R.T. Oliver, M.D. Mason, and G.M. Mead et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial Lancet 366 2005 293 300
8. T. Powles, D. Robinson, and J. Shamash et al. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis Ann Oncol 19 2008 443 447
9. P. Chung, and P. Warde Surveillance in stage I testicular seminoma Urol Oncol 24 2006 75 79
10. C.Y. Vossen, A. Horwich, and G. Daugaard et al. Patterns of care in the management of seminoma stage I: results from a European survey BJU Int 110 2012 524 531
11. F.H. Cafferty, R. Gabe, and R.A. Huddart et al. UK management practices in stage I seminoma and the Medical Research Council Trial of Imaging and Schedule in Seminoma Testis managed with surveillance Clin Oncol (R Coll Radiol) 24 2012 25 29
12. A.E. Thong, D.Y. Lichtensztajn, and L. Almario et al. Stage I testicular seminoma: a SEER analysis of contemporary adjuvant radiotherapy trends J Urol 190 2013 1240 1244
13. K.Y. Bilimoria, D.J. Bentrem, and A.K. Stewart et al. Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base J Clin Oncol 27 2009 4177 4181
14. K.Y. Bilimoria, A.K. Stewart, and D.P. Winchester et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States Ann Surg Oncol 15 2008 683 690
15. F. Greene AJCC Cancer Staging Manual: American Joint Committee on Cancer and American Cancer Society 2002 Springer-Verlag New York 421
16. I. Fleming AJCC Cancer Staging Manual: American Joint Committee on Cancer, American Cancer Society and American College of Surgeons Vol. XV 1997 Lippincott-Raven Philadelphia 294
17. L.B. Travis, S.D. Fossa, and S.J. Schonfeld et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors J Natl Cancer Inst 97 2005 1354 1365
18. T.V. Tarin, G. Sonn, and R. Shinghal Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography J Urol 181 2009 627 632 discussion 632-623
19. R.J. Motzer, N. Agarwal, and C. Beard et al. NCCN clinical practice guidelines in oncology: testicular cancer J Natl Compr Canc Netw 7 2009 672 693
20. P. Albers, W. Albrecht, and F. Algaba et al. EAU guidelines on testicular cancer: 2011 update Eur Urol 60 2011 304 319
21. D. Lewinshtein, R. Gulati, and P.S. Nelson et al. Incidence of second malignancies after external beam radiotherapy for clinical stage I testicular seminoma BJU Int 109 2012 706 712
22. T. Gilligan, W.K. Oh, and P.W. Kantoff Carboplatin for stage I seminoma J Clin Oncol 24 2006 2971 2972 author reply e2932-2973
23. P. Warde, L. Specht, and A. Horwich et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis J Clin Oncol 20 2002 4448 4452
24. N.D. Arvold, P.J. Catalano, and C.J. Sweeney et al. Barriers to the implementation of surveillance for stage I testicular seminoma Int J Radiat Oncol Biol Phys 84 2012 383 389
25. T.B. Powles, J. Bhardwa, and J. Shamash et al. The changing presentation of germ cell tumours of the testis between 1983 and 2002 BJU Int 95 2005 1197 1200